BioNTech SE (BNTX) Amortization (2018 - 2023)

BioNTech SE (BNTX) has 6 years of Amortization data on file, last reported at $21.7 billion in Q2 2023.

• In Q2 2023, Amortization rose 20.7% year-over-year to $21.7 billion; the TTM figure through Jun 2023 stood at $79.9 billion (up 51.65% YoY), while the FY2019 annual figure was $198323.3, up 247.85% from the prior year.
• Amortization steadied at $21.7 billion in Q2 2023, from $21.8 billion in the prior quarter.
• Across five years, Amortization topped out at $21.8 billion in Q1 2023 and bottomed at -$133.7 million in Q4 2019.
• A 5-year average of $8.0 billion and a median of $3.0 billion in 2021 frame the typical range for Amortization.
• Annual changes were most pronounced in 2019 — Amortization plunged 150.57% — and 2021, when it surged 5056.93%.
• Year by year, Amortization stood at -$133.7 million in 2019, then surged by 1359.66% to $1.7 billion in 2020, then surged by 510.09% to $10.3 billion in 2021, then jumped by 80.26% to $18.5 billion in 2022, then grew by 17.06% to $21.7 billion in 2023.
• The last three Amortization figures came in at $21.7 billion (Q2 2023), $21.8 billion (Q1 2023), and $18.5 billion (Q3 2022), per Business Quant data.

Peer Comparison